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To isolate the genes involved in the cell cycle G, phase progression of arterial smooth muscle cells (SMCs), a cDNA clone (Mil) was previously selected by differential hybridization screening of a mid-G, serum-stimulated SMC cDNA library. The delay of induction after mitogenic stimulation, time of expression, and need for new protein synthesis for full expression made it possible to classify this gene in the "delayed early" gene group. Determination of the partial Mil cDNA sequence showed full homology with the osteopontin gene (secreted phosphoprotein 1, 2ar), an Arg-Gly-Asp-containing extracellular matrix protein.
Osteopontin mRNA was also detected in the aorta at levels as high as in the kidney but lower than in bone, two tissues in which it has been previously detected. In vitro analysis of osteopontin expression in serum-stimulated quiescent SMCs and asynchronously cycling SMCs demonstrated that osteopontin overexpression was associated with SMC proliferation. In view of our results, the high osteopontin expression observed by others in the injured carotid artery could be explained by the involvement of SMCs in the proliferative process. Taken together, these results suggest that osteopontin may play an important role in pathological processes that are associated with arterial SMC proliferation, such as atherosclerosis or restenosis. {Arteriosclerosis and Thrombosis 1993;13:120-125) KEY WORDS • smooth muscle cells • osteopontin gene expression • delayed early genes • cell proliferation S mooth muscle cell (SMC) proliferation is an important feature in vascular disease and is believed to contribute to the development of pathologies such as atherosclerosis and restenosis. 1 -3 The similarities between pathological processes and arterial responses to experimental injury (e.g., endothelial denudation or a hypercholesterolemic diet) have led to the response-to-injury hypothesis developed by many investigators and reviewed by Ross and Glomset. 4 In this hypothesis, SMC activation, motility, and proliferation are the main responses to arterial injury. In vitro models that mimic in vivo activation, motility, and proliferation have been proposed that employ serum-deprived quiescent aortic SMCs in culture to study the events involved in these processes. 5 When quiescent SMCs are stimulated by mitogens such as serum, they leave the resting state (G o ), enter the cell cycle, and progress toward division through the G^ S, G 2 , and M phases. The biochemical mechanisms of the initial events during the Go/G, transition and G! phase progression are very complex and poorly understood. They include inositol trisphosphate turnover, an increase in intracellular pH and [Ca 2+ ], protein phosphorylation, and a time-dependent induction of the expression of a set of genes (cell cycle-dependent [CCD] genes). 6 " 13 In fibroblastic cell lines these CCD genes have been classified in relation to their delay of induction, time of maximal expression, and need for new protein synthesis.
14 This classification has recently been extended to arterial SMCs in culture. 10 Among CCD genes, the "immediate early" genes are induced the most rapidly, i.e., within the first 4 hours after mitogenic stimulation, even in the presence of cycloheximide. Although some "immediate early" genes have been implicated in the regulation of transcription (e.g., c-fos, fos B, jun, nerve growth factor-1, etc.), their functions remain unclear. The "late G," genes induced just before the G,/S transition are directly involved in mechanisms that control DNA synthesis (thymidine kinase, dihydrofolate reductase, and histones) and cell division (proliferating cell nuclear antigen) and can be considered as markers of cells that are involved in the proliferative process.
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The existence of a third intermediate group of genes, the "delayed early" genes whose early induction necessitates protein synthesis, has been suggested. 10 Because some of these genes may be involved in the cell's progression toward DNA synthesis and proliferation, identification and characterization of this kind of gene may be important in monitoring cell cycle progression and in investigating the mechanisms involved in the cascade of events that lead to arterial SMC proliferation both in vitro and in vivo. To identify additional genes in this family, one cDNA (Mil) has been cloned by differential screening of an 8-hour-stimulated SMC library (mid-d library) on the basis of its higher expression in 8-hour-than in 4-hour-stimulated SMCs. By comparison of its kinetics of expression in serumstimulated quiescent SMCs with those of other CCD genes, it was demonstrated that this gene belonged to the delayed early family. 10 In the present paper, Mil cDNA is identified as the osteopontin cDNA, and it is demonstrated that the expression of this gene is highly related to the proliferative state of arterial SMCs in culture.
Methods
Cell Culture
SMC secondary cultures obtained from normal rat aortas were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% (vol/vol) fetal calf serum (FCS), 10 mM Af-2-hydroxyethylpiperazineAf-2-ethanesulfonic acid (HEPES), and 1 mM pyruvate and were used between passages 6 and 18. Subconfluent quiescent SMCs (4xlO 4 cells/cm 2 ) were obtained by 48-hour serum deprivation. Cells were stimulated with fresh DMEM containing 10% FCS. When added to the medium, the cycloheximide (from Sigma) concentration was 1.5 ixglm\. Asynchronously cycling SMCs were obtained as described by Campan et al. 13 Cells were seeded at a low density (10 4 cells/cm 2 ) in a 75-cm 2 flask in 10% FCS-DMEM and allowed to grow for 3 days with a daily change of medium. The last change of medium was made exactly 24 hours before cell harvesting. In these conditions, the doubling time of these cells was about 24 hours. Cell counting was performed in an automatic cell counter (Coultronic ZM).
Elutriation and Flow Cytometric Analysis
Elutriation and flow cytometric analysis were performed as reported by Campan et al. 13 The SMC suspension (about 1.5 xlO 8 cells in DMEM, 2 mM ethylene glycol-bis(/3-aminoethyl ether)-Af,Af,iV',/V'-tetraacetic acid, and 1% bovine serum albumin) was injected at a flow rate of 6 ml/min into a Beckman JE-6B elutriator (Sanderson chamber) spinning at 1,500 rpm at 4°C. After stabilization of the cell gradient, elution of cell subpopulations was performed by increasing the flow rate to 7, 8.5, 10.5, 12, and 14 ml/min, respectively, for subpopulations a, b, c, d, and e. Cell cycle analysis of these elutriated subpopulations was monitored by flow cytometry. Cells were analyzed for DNA and RNA content with a cell sorter (ATC 3000-ODAM).
RNA Isolation and RNA Blot Analysis
Total RNA of cultured cells was isolated according to a technique modified from Hatch and Bonner. 16 Pellets of 10 6 cells in 1.5-ml microtubes were resuspended in 10 iu.l of 2% bentonite in phosphate-buffered saline and solubilized in 30 fi\ lysis buffer (6.3% [vol/vol] formaldehyde, 46% [vol/vol] formamide, 10 mM sodium acetate, 1 mM EDTA, 1.7% [wt/vol] SDS, and 40 mM 3-[JV-morpholino]propanesulfonic acid, pH 7). The resultant samples were heated at 65°C for 15 minutes and centrifuged at 4°C for 6 minutes at 12,000 rpm. Supernatants containing the total RNA content of 10 6 cells were immediately submitted to agarose gel electrophoresis or stored at -70°C. Total RNA from various tissues was isolated by acid guanidinium thiocyanate/ phenol/chloroform extraction. 17 Northern blotting and hybridization were performed according to the method of Maniatis et al. 18 Equivalent quantities of RNA in the different strips of the gel were confirmed by the equivalent ethidium bromide fluorescence of rRNA. Videometric analysis was performed with a video system and software from Biocom.
cDNA Clone Preparation and Sequence Analysis
The Mil cDNA clone was selected by differential plaque hybridization 18 of an 8-hour serum-stimulated SMC Agtll cDNA library as previously described. 10 Phages were cloned three times and amplified by the plate lysate method. 18 From selected plaques, Mil cDNA isolated by £coRI excision was subcloned into Bluescript plasmid (Stratagene) in two different clones containing the 260-bp 3' end and the 1.2-kbp 5' end, respectively, and the probes were prepared as described below. Furthermore, a constitutively expressed clone (Q21) encoding for mitochondrial rRNA was also selected from the cDNA library; it was used as a constitutive marker. DNA sequence analysis was performed with the dideoxy chain-termination technique. 19 GenBank was consulted for nucleotide sequence homology by using the FASTA program. 20 
DNA Probes and Radiolabeling
The 1.2-kbp Mil or 0.5-kbp Q21 cDNA fragments from Bluescript subclones were radiolabeled with deoxycytidine 5'-[a-32 P]triphosphate by using a randompriming DNA labeling kit (Amersham). The specific activities of the probes were in the range of 10 8 -10 9 cpm//ig DNA.
Results
Isolation and Identification of the Mil Gene
Differential hybridization screening of an 8-hour serum-stimulated SMC library (4xlO 5 recombinant phages) resulted in the isolation of 16 serum-inducible cDNA clones that showed a stronger hybridization signal with 8-hour than with 4-hour serum-stimulated SMC cDNA probes.
Among these cDNAs, nine of them hybridized with the largest (=1.5 kbp), Mil (Figure 1 ). cDNA from clone Mil was subcloned, and the nucleotide sequence of the 260-bp 5' end was determined. The search for homologies (GenBank) showed that this sequence perfectly matched the rat osteopontin 5' end cDNA sequence, 21 except that base 101 was T instead of C. A partial nucleotide sequence of the 1.2-kbp 3' end (~250-bp single determination for each side) and restriction enzyme analysis demonstrated the identity of the 3' end with that of osteopontin cDNA. This result suggests that Mil cDNA is the full-length cDNA of rat osteopontin.
Expression of Osteopontin mRNA in Cultured SMCs
Osteopontin expression in mitogen-stimulated cells. As previously reported for serum-deprived quiescent SMCs (seventh passage), 10 17th-passage SMCs also showed a low but detectable steady-state level of osteopontin mRNA as determined by Northern blot analysis. Addition of a 10% FCS-supplemented medium to subconfluent quiescent SMCs led to a strong and time-dependent induction of the expression of this gene (Figure 2A ) without any significant variation according to the number of cell passages. This expression was also dependent on new protein synthesis, since it was significantly inhibited by a cycloheximide concentration (1.5 /xg/ml) ( Figure  2C ) that was able to fully inhibit [ 3 H]leucine incorporation in trichloroacetic acid-precipitable material (not shown). Moreover, purified platelet-derived growth factor (30 jug) was able to induce osteopontin overexpression (not shown). The cellular content of the osteopontin mRNA transcript (1.6 kb) increased strongly from about the second hour after serum stimulation to the eighth hour and then remained high during progression through the first cell cycle (24 hours). In the absence of a change of medium, this content decreased on the second day after stimulation (Figure 2B ). During the subsequent evolution of the culture (third to eighth day), each change of medium (every 48 hours) was accompanied by a new induction of osteopontin gene expression ( Figure  3B ). As shown in Figure 3A , osteopontin reinduction in 48-hour-old cultures, for example, was transient, and its maximum was reached at about the eighth hour after serum refeeding. However, the level of this induction regularly decreased with subsequent changes of medium ( Figure 3B, lanes 3+, 4+, 6+, and 8+ ). This pattern paralleled that of cell proliferation as measured by the increase in cell number. Indeed, each change of medium induced a burst of proliferation that progressively decreased with time in culture ( Figure 3C ). When the culture reached the density of saturation (eighth day), cell proliferation was restricted to cell renewal, and the serum-induced expression of Mil was minimal. This suggests that osteopontin expression is associated with cell proliferation.
Osteopontin expression in asynchronously cycling cells. Twenty-four hours after the last change of medium, asynchronously cycling SMCs demonstrated a significant osteopontin expression (Figure 4) . Moreover, Mil mRNA determination in different subpopulations that represent the successive phases of the cell cycle showed that osteopontin expression was highly modulated ac- grams and normalization of osteopontin mRNA to the Q21 mRNA level showed a strong increase in the Mil to Q21 ratio associated with the enrichment of cell populations in G, b , S, and G 2 /M phases, respectively. This result demonstrates that osteopontin gene expression is highly related to cell cycle progression in continuously cycling SMCs.
Expression of Osteopontin In Vivo
As shown in Figure 5 osteopontin was expressed in the aorta, thereby confirming recently published results, 22 and the mRNA level was as high as in the kidney but lower than in bone, two tissues in which osteopontin expression has already been described. 23 In contrast, osteopontin expression was not detected by Northern blot analysis in several other tissues, including the liver, heart, brain, stomach, testis, intestine, lung, and skeletal muscle ( Figure 5 ), even after long-term autoradiography (3 weeks; not shown).
Discussion
In the search for genes that are involved in the mid-G, phase progression, differential hybridization screening has allowed us to select a CCD gene (Mil) from serum-stimulated SMCs in culture that is highly represented in the selected clone population. Its expression was shown to be strongly induced between the fourth and eighth hours after mitogenic stimulation of quiescent SMCs. 10 Its kinetics of expression in stimulated SMCs and the need for new protein synthesis for full expression (sensitivity to cycloheximide) confirm that the Mil gene belongs to the group of delayed early genes. Moreover, the stability of this type of kinetics of expression during cell passages suggests that its regulation is independent of the phenotypic modulation that occurs during cell passage. 24 cDNA cloning and sequencing have shown that this gene encodes osteopontin (2ar, sialoprotein I, 44-kD bone phosphoprotein, and secreted phosphoprotein I), a noncollagenous sialoprotein that was first isolated from mineral bone extracellular matrix 21222526 but that has also been immunodetected in other tissues and fluids (e.g., kidney, uterus, plasma, and milk). 27 
"
29 By Northern blot analysis, osteopontin mRNA was previously strongly detected in bone and the kidney, 23 aorta, and carotid artery. 22 The high steady-state level of osteopontin mRNA found in the aorta demonstrated that aortic tissue in conjunction with bone or the kidney was a relative specific site of osteopontin expression. It has also been previously shown that osteopontin mRNA is minimally expressed in the heart and stomach 22 ; however, despite the large amount of total RNA (40 jug) analyzed in each strip of the gel, no expression in either the heart or stomach was detected, thus confirming other works concerning osteopontin expression in heart tissue. 23 The present study demonstrates that the level of osteopontin expression is strongly increased after serum stimulation of cultured, quiescent, arterial SMCs, remains high during progression through the first cell cycle, and also remains high so long as the cells can proliferate, suggesting a strong association between osteopontin expression and SMC proliferation. Although other in vitro experiments have demonstrated an increase in osteopontin expression after growth factor, tumor promoter, or hormone stimulation of epithelial 30 or fibroblastic 31 cell lines, and although it has been reported that its expression is closely correlated with the neoplastic transformation of various cell lines, 31 -32 the function of this protein in cell proliferation has not been clearly established. Since osteopontin is an Arg-GlyAsp-containing protein that is involved in cell attachment and spreading, 21 it may intervene in the proliferative process by these pathways. However, osteopontin may act in other ways, as previously demonstrated for another extracellular matrix protein, thrombospondin, which has been directly implicated in the induction of cell proliferation. 33 -34 While the present paper shows the modulation of expression of osteopontin mRNA in SMCs that progress through the cell cycle in vitro, Giachelli et al 22 published a comparative study of osteopontin expression in rat pup and adult SMCs. That study showed that the osteopontin mRNA level was higher in cultured pup cells than in adult SMCs; in contrast, in vivo this level was lower in fetal or newborn aortas than in those of adults. In light of our results, it could be suggested that the higher osteopontin mRNA level in rat pup than in adult confluent SMCs in culture could result from the higher capacity of pup cells to proliferate under these culture conditions. Moreover, the strong increase in osteopontin mRNA expression observed by Giachelli et al 22 from the eighth hour after an endothelium-denuding injury of the carotid artery could also be related to the induction of SMC proliferation. Indeed, in this model, endothelial denudation was followed by rapid and strong SMC proliferation, as determined by thymidine incorporation, which reached a maximum at 48 hours in the media and at 96 hours in the intima. 35 Because the kinetics of osteopontin expression and SMC proliferation are quite parallel both in vivo and in vitro, our results that demonstrate the link between SMC proliferation in vitro and osteopontin mRNA expression suggest that the mRNA osteopontin overexpression observed after carotid artery injury may be partially related to SMC proliferation.
Taken together, these results clearly suggest that osteopontin expression is closely related to arterial SMC proliferation both in vitro and in vivo, and they raise the question of its physiological role in normal tissue and during pathological processes associated with arterial SMC proliferation, such as atherosclerosis or restenosis.
